From: Appropriate duration of post-surgical intravenous antibiotic therapy for pyogenic spondylodiscitis
Organism | All patients (n = 102) |
---|---|
Staphylococcus aureus | 41 (40.2%) |
Methicillin-susceptible S. aureus | 16 (15.7%) |
Methicillin-resistant S. aureus | 25 (24.5%) |
Coagulase-negative staphylococci | 4 (3.9%) |
Streptococcus species | 5 (4.9%) |
Viridans streptococcus | 3 (2.9%) |
Streptococcus sanguinis | 1 (1.0%) |
Group B streptococcus | 1 (1.0%) |
Gram-negative bacteria | 23 (22.5%) |
Escherichia coli | 6 (5.9%) |
Enterobacter species | 6 (5.9%) |
Klebsiella pneumoniae | 4 (3.9%) |
Pseudomonas aeruginosa | 4 (3.9%) |
Other gram-negative bacteria | 3 (2.9%) |
Anaerobes | 4 (3.9%) |
Culture-negative | 25 (24.5%) |